拱东医疗
(605369)
| 流通市值：45.05亿 | | | 总市值：45.05亿 |
| 流通股本：2.20亿 | | | 总股本：2.20亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 264,475,758.74 | 1,115,209,505.65 | 836,032,757.64 | 553,724,423.6 |
| 营业收入 | 264,475,758.74 | 1,115,209,505.65 | 836,032,757.64 | 553,724,423.6 |
| 二、营业总成本 | 227,405,060.17 | 930,246,460.51 | 683,540,594.88 | 449,296,008.47 |
| 营业成本 | 178,781,250.8 | 749,489,891.31 | 557,189,630.4 | 369,789,789.5 |
| 税金及附加 | 2,817,315.45 | 12,939,542.16 | 7,534,668.88 | 4,364,467.51 |
| 销售费用 | 9,277,291.08 | 51,995,319.48 | 34,257,821.93 | 24,026,114.3 |
| 管理费用 | 26,285,023.23 | 89,214,250.51 | 62,169,938.79 | 41,444,863.5 |
| 研发费用 | 10,632,536.55 | 53,045,507.65 | 36,769,587.06 | 23,675,602.46 |
| 财务费用 | -388,356.94 | -26,438,050.6 | -14,381,052.18 | -14,004,828.8 |
| 其中:利息费用 | 2,025,895.87 | 2,870,555.81 | 1,676,334.13 | 752,021.17 |
| 其中:利息收入 | -2,667,290.8 | 23,627,152.19 | 15,816,694.72 | 12,528,737.85 |
| 加:公允价值变动收益 | 1,574,728.67 | 4,071,171.28 | - | - |
| 加:投资收益 | -9,973,349.75 | 7,366,732.72 | 7,317,960.73 | 4,321,547.16 |
| 资产处置收益 | -150,100.84 | -20,506.38 | 6,024.33 | 6,024.33 |
| 资产减值损失(新) | -1,109,256.17 | -3,833,983.21 | -450,956.29 | -450,956.29 |
| 信用减值损失(新) | -761,850.23 | -4,524,512.8 | -3,544,850.21 | -3,106,210.55 |
| 其他收益 | 813,071.58 | 3,556,686.93 | 2,579,371.91 | 1,917,131.56 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 27,463,941.83 | 191,578,633.68 | 158,399,713.23 | 107,115,951.34 |
| 加:营业外收入 | 0.57 | 332,368.6 | 315,331.07 | 314,434.79 |
| 减:营业外支出 | 523,857.56 | 3,175,850.44 | 605,698.1 | 305,698.1 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 26,940,084.84 | 188,735,151.84 | 158,109,346.2 | 107,124,688.03 |
| 减:所得税费用 | -322,183.98 | 17,231,276.08 | 16,726,505.45 | 11,831,008.07 |
| 六、净利润 | 27,262,268.82 | 171,503,875.76 | 141,382,840.75 | 95,293,679.96 |
| 持续经营净利润 | 27,262,268.82 | 171,503,875.76 | 141,382,840.75 | 95,293,679.96 |
| 归属于母公司股东的净利润 | 27,412,464.23 | 171,632,798.29 | 141,396,726.29 | 95,293,679.96 |
| 少数股东损益 | -150,195.41 | -128,922.53 | -13,885.54 | - |
| (一)基本每股收益 | 0.17 | 1.09 | 0.9 | 0.85 |
| (二)稀释每股收益 | 0.17 | 1.09 | 0.9 | 0.85 |
| 八、其他综合收益 | -633,649.32 | 5,907,295.68 | -5,610,871.98 | 1,702,460.45 |
| 归属于母公司股东的其他综合收益 | -633,649.32 | 5,907,295.68 | -5,610,871.98 | 1,702,460.45 |
| 九、综合收益总额 | 26,628,619.5 | 177,411,171.44 | 135,771,968.77 | 96,996,140.41 |
| 归属于母公司股东的综合收益总额 | 26,778,814.91 | 177,540,093.97 | 135,785,854.31 | 96,996,140.41 |
| 归属于少数股东的综合收益总额 | -150,195.41 | -128,922.53 | -13,885.54 | - |
| 公告日期 | 2025-04-26 | 2025-04-22 | 2024-10-30 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |